Gene delivery by peptide-assisted transport
The diverse amino acid chemistries and secondary structures in peptides provide 'minimalist' mimics of motifs in proteins and offer many ideal properties for targeted delivery approaches. Several non-viral vectors (polymers and lipids) have been studied for their potential applications in gene delivery. However, non-specific uptake, lack of targeting, inability to escape endosomes, and inefficient nuclear delivery limit their application. Peptide-assisted trafficking of non-viral vectors can potentially overcome these biological barriers to improve gene delivery through targeted uptake using key cell-surface receptors (e.g., integrins, growth factor receptors, and G-protein coupled receptors); membrane disruption for endosomal escape; and nuclear importation. Furthermore, the capacity of peptides to regulate spatio-temporal control over gene delivery opens multi-faceted avenues for effective gene delivery in a variety of complex applications. Rigorous on-going in vitro and in vivo studies utilizing peptides for targeted and microenvironment-sensitive gene delivery could promote their widespread clinical usage.
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2018 |
|---|---|
| Erschienen: |
2018 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:7 |
|---|---|
| Enthalten in: |
Current opinion in biomedical engineering - 7(2018) vom: 13. Sept., Seite 71-82 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Thapa, Raj Kumar [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
Cell penetrating peptide |
|---|
| Anmerkungen: |
Date Revised 06.10.2023 published: Print-Electronic Citation Status PubMed-not-MEDLINE |
|---|
| doi: |
10.1016/j.cobme.2018.10.002 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM295294000 |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM295294000 | ||
| 003 | DE-627 | ||
| 005 | 20231225083340.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231225s2018 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1016/j.cobme.2018.10.002 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n0984.xml |
| 035 | |a (DE-627)NLM295294000 | ||
| 035 | |a (NLM)30906908 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Thapa, Raj Kumar |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Gene delivery by peptide-assisted transport |
| 264 | 1 | |c 2018 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Revised 06.10.2023 | ||
| 500 | |a published: Print-Electronic | ||
| 500 | |a Citation Status PubMed-not-MEDLINE | ||
| 520 | |a The diverse amino acid chemistries and secondary structures in peptides provide 'minimalist' mimics of motifs in proteins and offer many ideal properties for targeted delivery approaches. Several non-viral vectors (polymers and lipids) have been studied for their potential applications in gene delivery. However, non-specific uptake, lack of targeting, inability to escape endosomes, and inefficient nuclear delivery limit their application. Peptide-assisted trafficking of non-viral vectors can potentially overcome these biological barriers to improve gene delivery through targeted uptake using key cell-surface receptors (e.g., integrins, growth factor receptors, and G-protein coupled receptors); membrane disruption for endosomal escape; and nuclear importation. Furthermore, the capacity of peptides to regulate spatio-temporal control over gene delivery opens multi-faceted avenues for effective gene delivery in a variety of complex applications. Rigorous on-going in vitro and in vivo studies utilizing peptides for targeted and microenvironment-sensitive gene delivery could promote their widespread clinical usage | ||
| 650 | 4 | |a Journal Article | |
| 650 | 4 | |a Cell penetrating peptide | |
| 650 | 4 | |a DNA | |
| 650 | 4 | |a gene delivery | |
| 650 | 4 | |a non-viral vectors | |
| 650 | 4 | |a peptide | |
| 700 | 1 | |a Sullivan, Millicent O |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Current opinion in biomedical engineering |d 2017 |g 7(2018) vom: 13. Sept., Seite 71-82 |w (DE-627)NLM277074975 |x 2468-4511 |7 nnns |
| 773 | 1 | 8 | |g volume:7 |g year:2018 |g day:13 |g month:09 |g pages:71-82 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1016/j.cobme.2018.10.002 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 7 |j 2018 |b 13 |c 09 |h 71-82 | ||